Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperparathyroidism

M Horowitz1, J M Wishart, A G Need

  • 1Department of Medicine, Royal Adelaide Hospital, Australia.

Clinics in Geriatric Medicine
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of dietary calcium in the definition of hypercalciuria.

British medical journal·2010
Same author

Relationship between calcium absorption and plasma dehydroepiandrosterone sulphate (DHEAS) in healthy males.

Clinical endocrinology·2008
Same author

Relation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to calcitriol.

European journal of clinical nutrition·2004
Same author

Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency.

Bone·2002
Same author

Bone density and bone-related biochemical variables in normal men: a longitudinal study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2002
Same author

Effect of perimenopause on calcium absorption: a longitudinal study.

Climacteric : the journal of the International Menopause Society·2002
Same journal

Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

Clinics in geriatric medicine·2026
Same journal

Preventive Cardiology for the Clinically Complex Older Adult.

Clinics in geriatric medicine·2026
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
See all related articles

Primary hyperparathyroidism is a common endocrine disorder, especially in women over 50. Treatment is advised for symptomatic patients or those with significant bone loss or high calcium levels.

Area of Science:

  • Endocrinology
  • Metabolic Bone Disease

Background:

  • Primary hyperparathyroidism (PHPT) is an endocrine disorder.
  • It affects up to 3% of postmenopausal women and is often asymptomatic, discovered incidentally via blood tests.
  • The prevalence increases significantly after age 50.

Purpose of the Study:

  • To outline the diagnostic criteria and treatment recommendations for primary hyperparathyroidism.
  • To discuss the management of both symptomatic and asymptomatic PHPT, particularly concerning bone health.

Main Methods:

  • Review of clinical guidelines and literature on PHPT diagnosis and management.
  • Analysis of indications for surgical intervention based on specific clinical and biochemical parameters.

Main Results:

Related Experiment Videos

  • Surgical treatment is recommended for PHPT patients with renal stones, plasma calcium > 3 mmol/L, or accelerated bone loss (e.g., bone density < -3 SD).
  • Debate exists regarding treatment for mild, asymptomatic PHPT.
  • Rapid bone loss necessitates either surgical or medical therapy (hormones, bisphosphonates).

Conclusions:

  • Primary hyperparathyroidism management requires careful consideration of patient symptoms, calcium levels, and bone density.
  • Intervention is clearly indicated for severe disease manifestations, while mild cases warrant individualized assessment.
  • Hormone therapy and bisphosphonates are viable medical treatment options.